Eton Pharmaceuticals
ETON
#5395
Rank
โ‚ฌ1.43 B
Marketcap
50,24ย โ‚ฌ
Share price
-2.42%
Change (1 day)
N/A
Change (1 year)

Revenue for Eton Pharmaceuticals (ETON)

Revenue in 2026 (TTM): โ‚ฌ91.15 Million

According to Eton Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ90.75 Million. In 2025 the company made a revenue of โ‚ฌ68.05 Million an increase over the revenue in the year 2024 that were of โ‚ฌ37.48 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eton Pharmaceuticals from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ91.15 M33.93%
2025 โ‚ฌ68.05 M81.54%
2024 โ‚ฌ37.48 M30.97%
2023 โ‚ฌ28.62 M44.48%
2022 โ‚ฌ19.81 M2.77%
2021 โ‚ฌ19.27 M60698.25%
2020 โ‚ฌ0.03 M-96.3%
2019 โ‚ฌ0.85 M
2018 N/A